Why Novartis, Seelos Therapeutics And More Are Moving Today

Allogene Therapeutics ALLO shares are trading higher Tuesday after Stifel upgraded the stock from Hold to Buy and raised its price target from $33 to $43 per share.

Allogene is a U.S.-based clinical-stage immuno-oncology company. It's mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.

Allogene Therapeutics shares were trading up 3.55% at $34.15. The stock has a 52-week high of $55 and a 52-week low of $17.43.

Selecta Biosciences SELB shares are trading higher after Mizuho upgraded the stock from Neutral to Buy and raised its price target from $2.5 to $8 per share.

Selecta Biosciences is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases.

Selecta Biosciences shares traded up 5.93% to $4.28. The stock has a 52-week high of $4.83 and a 52-week low of $1.42.

Novartis NVS shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results.

Novartis develops and manufactures health care products through two segments: Innovative Medicines and Sandoz.

Novartis shares were trading down 3.56% at $95. The stock has a 52-week high of $99.84 and a 52-week low of $69.18.

Seelos Therapeutics SEEL shares are trading lower after the company reported a common stock offering. No size was disclosed.

Seelos Therapeutics is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer.

Seelos Therapeutics shares were trading down 13.55% at $2.30 The stock has a 52-week high of $3.20 and a 52-week low of 42 cents.